Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Oct 1.

Published in final edited form as: Eur Urol Oncol. 2019 Jul 2;3(5):687–694. doi: 10.1016/j.euo.2019.06.004

Fig. 3– — Association between baseline and mean patient-reported outcomes at 3 mo by treatment group. The shaded areas represent the 95% confidence bands for each curve, with the darker shade representing the region in which the confidence intervals overlap. CES-D = Center for Epidemiologic Studies—Depression; FACT-G = Functional Assessment of Cancer Therapy— General; FKSI-15 = 15-item Kidney Symptom Index.

Fig. 3– — Association between baseline and mean patient-reported outcomes at 3 mo by treatment group. The shaded areas represent the 95% confidence bands for each curve, with the darker shade representing the region in which the confidence intervals overlap. CES-D = Center for Epidemiologic Studies—Depression; FACT-G = Functional Assessment of Cancer Therapy— General; FKSI-15 = 15-item Kidney Symptom Index.